![]() | |
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
ChEMBL | |
Chemical and physical data | |
Formula | C18H13ClFNO3S |
Molar mass | 377.81 g·mol−1 |
3D model ( JSmol) | |
| |
|
![]() | This article provides insufficient context for those unfamiliar with the subject.(March 2021) |
CU-CPT4a is a drug which acts as a selective antagonist of Toll-like receptor 3 (TLR3), with an IC50 of 3.44 μM. It is used for research into the function of TRL3 and its role in inflammation, autoimmune disorders and cancer. [1] [2]
![]() | |
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
ChEMBL | |
Chemical and physical data | |
Formula | C18H13ClFNO3S |
Molar mass | 377.81 g·mol−1 |
3D model ( JSmol) | |
| |
|
![]() | This article provides insufficient context for those unfamiliar with the subject.(March 2021) |
CU-CPT4a is a drug which acts as a selective antagonist of Toll-like receptor 3 (TLR3), with an IC50 of 3.44 μM. It is used for research into the function of TRL3 and its role in inflammation, autoimmune disorders and cancer. [1] [2]